TY - JOUR
T1 - HLA-A*02 subtype distribution in Caucasians from northern Italy
T2 - Identification of A*0220
AU - Fleischhauer, K.
AU - Zino, E.
AU - Mazzi, B.
AU - Severini, G. M.
AU - Benazzi, E.
AU - Bordignon, C.
PY - 1996
Y1 - 1996
N2 - This study describes a comprehensive, easy to perform PCR-SSOP typing approach suitable for complete genomic subtyping of HLA-A*02. A single 1.6 kb PCR-amplificate spanning exons 2, 3 and 4 of the HLA-A*02 gene was used for hybridization with a panel of twenty-four SSOPs. This allowed unequivocal assignment of all so far known HLA-A2 subtypes, including A*0209 and A*0215N which differ for nucleotide substitutions in exon 4, without the need for two separate amplifications. Using this approach, HLA-A*02 subtype distribution was analyzed in 218 samples from unrelated, healthy individuals from northern Italy enrolled in the Italian Bone Marrow Registry and typed as HLA-A2 by serology or generic molecular analysis. As expected, A*0201 was found in the majority (92.6%) of samples. However, a significant number (6.8%) of individuals carried A':0205. Furthermore, A'0202, A'0208, A'0209 and A'0217, so far not described in Caucasians, were detected in a low number of samples (frequency ranging from 0.45% to 1.8%). Finally, a novel HLA-A'02 subtype, A'0220, was detected in 0.9% of the samples. As confirmed by DNA sequencing of exons 2 and 3, this allele is identical to A'0201 except for a single nucleotide substitution in codon 66 which changes the predicted amino acid sequence form Lys to Asn. The findings of this study have implications for the selection of HLA-A'02' donors in unrelated bone marrow transplantation and of patients for specific immunetherapy with HLA-A'02 restricted peptide vaccines.
AB - This study describes a comprehensive, easy to perform PCR-SSOP typing approach suitable for complete genomic subtyping of HLA-A*02. A single 1.6 kb PCR-amplificate spanning exons 2, 3 and 4 of the HLA-A*02 gene was used for hybridization with a panel of twenty-four SSOPs. This allowed unequivocal assignment of all so far known HLA-A2 subtypes, including A*0209 and A*0215N which differ for nucleotide substitutions in exon 4, without the need for two separate amplifications. Using this approach, HLA-A*02 subtype distribution was analyzed in 218 samples from unrelated, healthy individuals from northern Italy enrolled in the Italian Bone Marrow Registry and typed as HLA-A2 by serology or generic molecular analysis. As expected, A*0201 was found in the majority (92.6%) of samples. However, a significant number (6.8%) of individuals carried A':0205. Furthermore, A'0202, A'0208, A'0209 and A'0217, so far not described in Caucasians, were detected in a low number of samples (frequency ranging from 0.45% to 1.8%). Finally, a novel HLA-A'02 subtype, A'0220, was detected in 0.9% of the samples. As confirmed by DNA sequencing of exons 2 and 3, this allele is identical to A'0201 except for a single nucleotide substitution in codon 66 which changes the predicted amino acid sequence form Lys to Asn. The findings of this study have implications for the selection of HLA-A'02' donors in unrelated bone marrow transplantation and of patients for specific immunetherapy with HLA-A'02 restricted peptide vaccines.
KW - A0220
KW - HLA-A2 subtypes
KW - PCR-SSOP
KW - Population study
UR - http://www.scopus.com/inward/record.url?scp=0030300032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030300032&partnerID=8YFLogxK
M3 - Article
C2 - 9008310
AN - SCOPUS:0030300032
VL - 48
SP - 673
EP - 679
JO - Tissue Antigens
JF - Tissue Antigens
SN - 0001-2815
IS - 6
ER -